Skip to main content
SpringerLink
Log in
Book cover

Intersphincteric Resection for Low Rectal Tumors pp 43–53Cite as

Selective non-operative management of distal rectal cancer: The Watch & Wait Protocol

  • Chapter

Abstract

The observation of improved local disease control with the use of preoperative chemoradiation (CRT) for locally advanced rectal cancer established this treatment strategy as one the preferred initial approaches for this disease. Interestingly, the benefits of preoperative CRT were not restricted to local recurrence rates but also included reduced toxicity rates compared to postoperative CRT, significant tumor downstaging and downsizing, greater rates of sphincter preservation, and better functional results [1, 2].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Habr-Gama A, Perez RO, Kiss DR, Rawet V, Scanavini A, Santinho PM, Nadalin W (2004) Preoperative chemoradiation therapy for low rectal cancer. Impact on downstaging and sphincter-saving operations. Hepato-gastroenterol 51(60): 1703–1707

    Google Scholar 

  2. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351(17): 1731–1740

    Article  PubMed  CAS  Google Scholar 

  3. Chessin DB, Enker W, Cohen AM, Paty PB, Weiser MR, Saltz L, Minsky BD, Wong WD, Guillem JG (2005) Complications after preoperative combined modality therapy and radical resection of locally advanced rectal cancer: a 14-year experience from a specialty service. JAmColl Surg 200(6): 876–882; discussion 82–84

    Google Scholar 

  4. Matthiessen P, Hallbook O, Andersson M, Rutegard J, Sjodahl R (2004) Risk factors for anastomotic leakage after anterior resection of the rectum. Colorectal Dis 6(6): 462–469

    Article  PubMed  CAS  Google Scholar 

  5. Eriksen MT, Wibe A, Norstein J, Haffner J, Wiig JN (2005) Anastomotic leakage following routine mesorectal excision for rectal cancer in a national cohort of patients. Colorectal Dis 7(1): 51–57

    Article  PubMed  CAS  Google Scholar 

  6. Perez RO, Habr-Gama A, Seid VE, Proscurshim I, Sousa AH Jr, Kiss DR, Linhares M, Sapucahy M, Gama-Rodrigues J (2006) Loop ileostomy morbidity: timing of closure matters. Dis Colon Rectum 49(10): 1539–1545

    Article  PubMed  Google Scholar 

  7. Denost Q, Laurent C, Capdepont M, Zerbib F, Rullier E (2011) Risk factors for fecal incontinence after intersphincteric resection for rectal cancer. Dis Colon Rectum 54(8): 963–968

    Article  PubMed  Google Scholar 

  8. Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Saltz LB, Goodman KA, Minsky BD, Wong WD, Weiser MR (2008) Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer 113(1): 57–64

    Article  PubMed  Google Scholar 

  9. Maas M, Nelemans PJ, Valentini V, Das P, Rodel C, Kuo LJ, Calvo FA, Garcia-Aguilar J, Glynne-Jones R, Haustermans K, Mohiuddin M, Pucciarelli S, Small W Jr, Suarez J, Theodoropoulos G, Biondo S, Beets-Tan RG, Beets GL (2010) Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 11(9): 835–844

    Article  PubMed  Google Scholar 

  10. Hiotis SP, Weber SM, Cohen AM, Minsky BD, Paty PB, Guillem JG, Wagman R, Saltz LB, Wong WD (2002) Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg 194(2): 131–135; discussion 5–6

    Article  Google Scholar 

  11. Habr-Gama A, Perez RO, Wynn G, Marks J, Kessler H, Gama-Rodrigues J (2010) Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization. Dis Colon Rectum 53(12): 1692–1698

    Article  PubMed  Google Scholar 

  12. Mezzi G, Arcidiacono PG, Carrara S, Perri F, Petrone MC, De Cobelli F, Gusmini S, Staudacher C, Del Maschio A, Testoni PA (2009) Endoscopic ultrasound and magnetic resonance imaging for re-staging rectal cancer after radiotherapy. World J Gastroenterol 15(44): 5563–5567

    Article  PubMed  Google Scholar 

  13. Suppiah A, Hunter IA, Cowley J, Garimella V, Cast J, Hartley JE, Monson JR (2009) Magnetic resonance imaging accuracy in assessing tumour down-staging following chemoradiation in rectal cancer. Colorectal Dis 11(3): 249–253

    Article  PubMed  CAS  Google Scholar 

  14. Kim YH, Kim DY, Kim TH, Jung KH, Chang HJ, Jeong SY, Sohn DK, Choi HS, Ahn JB, Kim DH, Lim SB, Lee JS, Park JG (2005) Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer. Int J Radiat Oncol Biol Phys 62(3): 761–768

    Article  PubMed  Google Scholar 

  15. Kang JH, Kim YC, Kim H, Kim YW, Hur H, Kim JS, Min BS, Kim H, Lim JS, Seong J, Keum KC, Kim NK (2010) Tumor volume changes assessed by three-dimensional magnetic resonance volumetry in rectal cancer patients after preoperative chemoradiation: the impact of the volume reduction ratio on the prediction of pathologic complete response. Int J Radiat Oncol Biol Phys 76(4): 1018–1025

    Article  PubMed  Google Scholar 

  16. Lambregts DM, Vandecaveye V, Barbaro B, Bakers FC, Lambrecht M, Maas M, Haustermans K, Valentini V, Beets GL, Beets-Tan RG (2011) Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol 18(8): 2224–2231

    Article  PubMed  Google Scholar 

  17. Curvo-Semedo L, Lambregts DM, Maas M, Thywissen T, Mehsen RT, Lammering G, Beets GL, Caseiro-Alves F, Beets-Tan RG (2011) Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy — Conventional MR volumetry versus diffusion-weighted MR imaging. Radiology 260(3): 734–743

    Article  Google Scholar 

  18. Calvo FA, Domper M, Matute R, Martinez-Lazaro R, Arranz JA, Desco M, Alvarez E, Carreras JL (2004) 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 58(2): 528–535

    Article  PubMed  Google Scholar 

  19. Guillem JG, Puig-La Calle J Jr, Akhurst T, Tickoo S, Ruo L, Minsky BD, Gollub MJ, Klimstra DS, Mazumdar M, Paty PB, Macapinlac H, Yeung H, Saltz L, Finn RD, Erdi Y, Humm J, Cohen AM, Larson S (2000) Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. Dis Colon Rectum 43(1): 18–24

    Article  PubMed  CAS  Google Scholar 

  20. Kristiansen C, Loft A, Berthelsen AK, Graff J, Lindebjerg J, Bisgaard C, Jakobsen A (2008) PET/CT and histopathologic response to preoperative chemoradiation therapy in locally advanced rectal cancer. Dis Colon Rectum 51(1): 21–25

    Article  PubMed  Google Scholar 

  21. Perez RO, Habr-Gama A, Julião GPS, Gama-Rodrigues J, Proscurshim I, Lynn P, Ono C, Campos F, Sousa Jr. AS, Imperiale A, Nahas S, Buchpiguel C (2011) Accuracy of PET/CT and clinical assessment in the detection of complete rectal tumor regression following neoadjuvant chemoradiation. Long-term results of a prospective trial (NCT00254683). Cancer (in press)

    Google Scholar 

  22. Moreno Garcia V, Cejas P, Blanco Codesido M, Feliu Batlle J, de Castro Carpeno J, Belda-Iniesta C, Barriuso J, Sanchez JJ, Larrauri J, Gonzalez-Baron M, Casado E (2009) Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy. Int J Colorectal Dis 24(7): 741–748

    Article  PubMed  CAS  Google Scholar 

  23. Kim CW, Yu CS, Yang SS, Kim KH, Yoon YS, Yoon SN, Lim SB, Kim JC (2011) Clinical significance of pre-to postchemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol 18(2): 3271–3277

    Article  PubMed  Google Scholar 

  24. Jang NY, Kang SB, Kim DW, Kim JH, Lee KW, Kim IA, Kim JS (2011) The role of carcinoembryonic antigen after neoadjuvant chemoradiotherapy in patients with rectal cancer. Dis Colon Rectum 54(2): 245–252

    Article  PubMed  Google Scholar 

  25. Perez RO, Habr-Gama A, São Julião GP, Proscurshim I, Kiss DR, Gama-Rodrigues J, Cecconello I (2009) The role of CEA in predicting response and survival to neoadjuvant CRT for distal rectal cancer. Dis Colon Rectum (in press)

    Google Scholar 

  26. Meterissian S, Skibber J, Rich T, Roubein L, Ajani J, Cleary K, Ota DM (1994) Patterns of residual disease after preoperative chemoradiation in ultrasound T3 rectal carcinoma. Ann Surg Oncol 1(2): 111–116

    Article  PubMed  CAS  Google Scholar 

  27. Perez RO (2011) The role of biopsies in patients with residual rectal cancer following neoadjuvant chemoradiation after downsizing: can they rule out persisting cancer? Colorectal Dis (in press)

    Google Scholar 

  28. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M (2006) Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93(10): 1215–1223

    Article  PubMed  CAS  Google Scholar 

  29. Bosset JF, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Briffaux A, Collette L (2005) Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results — EORTC 22921. J Clin Oncol 23(24): 5620–5627

    Article  PubMed  CAS  Google Scholar 

  30. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355(11): 1114–1123

    Article  PubMed  CAS  Google Scholar 

  31. Sanghera P, Wong DW, McConkey CC, Geh JI, Hartley A (2008) Chemoradiotherapy for rectal cancer: an updated analysis of factors affecting pathological response. Clin Oncol (R Coll Radiol) 20(2): 176–183

    Article  CAS  Google Scholar 

  32. Gerard JP, Azria D, Gourgou-Bourgade S, Martel-Laffay I, Hennequin C, Etienne PL, Vendrely V, Francois E, de La Roche G, Bouche O, Mirabel X, Denis B, Mineur L, Berdah JF, Mahe MA, Becouarn Y, Dupuis O, Lledo G, Montoto-Grillot C, Conroy T (2010) Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 28(10): 1638–1644

    Article  PubMed  CAS  Google Scholar 

  33. Weiss C, Arnold D, Dellas K, Liersch T, Hipp M, Fietkau R, Sauer R, Hinke A, Rodel C (2010) Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: a pooled analysis of three prospective phase I-II trials. Int J Radiat Oncol Biol Phys 78(2): 472–478

    Article  PubMed  CAS  Google Scholar 

  34. Glynne-Jones R, Mawdsley S, Harrison M (2010) Cetuximab and chemoradiation for rectal cancer — is the water getting muddy? Acta Oncol 49(3): 278–286

    Article  PubMed  CAS  Google Scholar 

  35. Francois Y, Nemoz CJ, Baulieux J, Vignal J, Grandjean JP, Partensky C, Souquet JC, Adeleine P, Gerard JP (1999) Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphinctersparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 17(8): 2396

    PubMed  CAS  Google Scholar 

  36. Moore HG, Gittleman AE, Minsky BD, Wong D, Paty PB, Weiser M, Temple L, Saltz L, Shia J, Guillem JG (2004) Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum 47(3): 279–286

    Article  PubMed  Google Scholar 

  37. Tulchinsky H, Shmueli E, Figer A, Klausner JM, Rabau M (2008) An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and diseasefree survival in patients with locally advanced rectal cancer. Ann Surg Oncol 15(10): 2661–2667

    Article  PubMed  Google Scholar 

  38. Kalady MF, de Campos-Lobato LF, Stocchi L, Geisler DP, Dietz D, Lavery IC, Fazio VW (2009) Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer. Ann Surg 250(4): 582–589

    PubMed  Google Scholar 

  39. Garcia-Aguilar J, Smith DD, Avila K, Bergsland EK, Chu P, Krieg RM (2011) Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial. Ann Surg 254(1): 97–102

    Article  PubMed  Google Scholar 

  40. Withers HR, Haustermans K (2004) Where next with preoperative radiation therapy for rectal cancer? Int J Radiat Oncol Biol Phys 58(2): 597–602

    Article  PubMed  Google Scholar 

  41. Kerr SF, Norton S, Glynne-Jones R (2008) Delaying surgery after neoadjuvant chemoradiotherapy for rectal cancer may reduce postoperative morbidity without compromising prognosis. Br J Surg 95(12): 1534–1540

    Article  PubMed  CAS  Google Scholar 

  42. Habr-Gama A, Perez RO, Proscurshim I, Nunes Dos Santos RM, Kiss D, Gama-Rodrigues J, Cecconello I (2008) Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome? Int J Radiat Oncol Biol Phys 71(4): 1181–1188

    Article  PubMed  Google Scholar 

  43. Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Wolff RA, Eng C, Krishnan S, Janjan NA, Crane CH (2007) Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer 109(9): 1750–1755

    Article  PubMed  CAS  Google Scholar 

  44. Ghadimi BM, Grade M, Difilippantonio MJ, Varma S, Simon R, Montagna C, Fuzesi L, Langer C, Becker H, Liersch T, Ried T (2005) Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol 23(9): 1826–1838

    Article  PubMed  CAS  Google Scholar 

  45. Kim IJ, Lim SB, Kang HC, Chang HJ, Ahn SA, Park HW, Jang SG, Park JH, Kim DY, Jung KH, Choi HS, Jeong SY, Sohn DK, Kim DW, Park JG (2007) Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer. Dis Colon Rectum 50(9): 1342–1353

    Article  PubMed  Google Scholar 

  46. Rimkus C, Friederichs J, Boulesteix AL, Theisen J, Mages J, Becker K, Nekarda H, Rosenberg R, Janssen KP, Siewert JR (2008) Microarray-based prediction of tumor response to neoadjuvant radiochemotherapy of patients with locally advanced rectal cancer. Clin Gastroenterol Hepatol 6(1): 53–61

    Article  PubMed  CAS  Google Scholar 

  47. Perez RO (2011) Predicting response to neoadjuvant treatment for rectal cancer: a step toward individualized medicine. Dis Colon Rectum 54(9): 1057–1058

    Article  PubMed  Google Scholar 

  48. Garcia-Aguilar J, Chen Z, Smith DD, Li W, Madoff RD, Cataldo P, Marcet J, Pastor C (2011) Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer. Ann Surg 254(3): 486–493

    Article  PubMed  Google Scholar 

  49. Habr-Gama A, de Souza PM, Ribeiro U Jr, Nadalin W, Gansl R, Sousa AH Jr, Campos FG, Gama-Rodrigues J (1998) Low rectal cancer: impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum 41(9): 1087–1096

    Article  PubMed  CAS  Google Scholar 

  50. Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U Jr, Silvae Sousa AH Jr, Campos FG, Kiss DR, Gama-Rodrigues J (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: longterm results. Ann Surg 240(4): 711–717; discussion 7–8

    PubMed  Google Scholar 

  51. Habr-Gama A, Perez RO, Proscurshim I, Campos FG, Nadalin W, Kiss D, Gama-Rodrigues J (2006) Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg 10(10): 1319–1328; discussion 28–29

    Article  PubMed  Google Scholar 

  52. Habr-Gama A, Perez RO, Sabbaga J, Nadalin W, Sao Juliao GP, Gama-Rodrigues J (2009) Increasing the rates of complete response to neoadjuvant chemoradiotherapy for distal rectal cancer: results of a prospective study using additional chemotherapy during the resting period. Dis Colon Rectum 52(12): 1927–1934

    Article  PubMed  Google Scholar 

  53. Chua YJ, Barbachano Y, Cunningham D, Oates JR, Brown G, Wotherspoon A, Tait D, Massey A, Tebbutt NC, Chau I (2010) Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial. Lancet Oncol 11(3): 241–248

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Angelita & Joaquim Gama Institute, Rua Manoel da Nóbrega 1564, São Paulo, Brazil, CEP 04001-005

    Angelita Habr-Gama MD, Rodrigo O. Perez MD, PhD, Patricio B. Lynn MD, Guilherme Pagin São Julião MD & Joaquim José Gama Rodrigues (Professor of Surgery)

  2. School of Medicine, University of Sao Paulo, São Paulo, Brazil

    Rodrigo O. Perez MD, PhD, Guilherme Pagin São Julião MD & Joaquim José Gama Rodrigues (Professor of Surgery)

Authors
  1. Angelita Habr-Gama MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rodrigo O. Perez MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patricio B. Lynn MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Guilherme Pagin São Julião MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Joaquim José Gama Rodrigues
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Angelita Habr-Gama MD .

Editor information

Editors and Affiliations

  1. Ludwig Boltzmann Institute for Surgical Oncology, Vienna, Austria

    Rudolf Schiessel MD

  2. Surgical Department, Danube Hospital, Vienna, Austria

    Peter Metzger MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag/Wien

About this chapter

Cite this chapter

Habr-Gama, A., Perez, R.O., Lynn, P.B., São Julião, G.P., Gama Rodrigues, J.J. (2012). Selective non-operative management of distal rectal cancer: The Watch & Wait Protocol. In: Schiessel, R., Metzger, P. (eds) Intersphincteric Resection for Low Rectal Tumors. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0929-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-0929-8_4

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-0928-1

  • Online ISBN: 978-3-7091-0929-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation